Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis

Documenti analoghi

• Non‐invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways
  di: Verhoef, Talitha I., et al.
  Pubblicazione: (2016)
• Preferences for Prenatal Tests for Cystic Fibrosis: A Discrete Choice Experiment to Compare the Views of Adult Patients, Carriers of Cystic Fibrosis and Health Professionals
  di: Hill, Melissa, et al.
  Pubblicazione: (2014)
• Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
  di: Chitty, Lyn S, et al.
  Pubblicazione: (2016)
• Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach
  di: Chitty, Lyn S, et al.
  Pubblicazione: (2015)
• Limited Clinical Utility of Non-invasive Prenatal Testing for Subchromosomal Abnormalities
  di: Lo, Kitty K., et al.
  Pubblicazione: (2016)